State of New Jersey Common Pension Fund D Boosts Position in ICU Medical, Inc. (NASDAQ:ICUI)

State of New Jersey Common Pension Fund D lifted its position in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 74.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 29,573 shares of the medical instruments supplier's stock after acquiring an additional 12,660 shares during the period. State of New Jersey Common Pension Fund D owned 0.12% of ICU Medical worth $2,950,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in ICUI. Private Trust Co. NA lifted its position in ICU Medical by 1,428.6% during the third quarter. Private Trust Co. NA now owns 321 shares of the medical instruments supplier's stock valued at $38,000 after purchasing an additional 300 shares during the period. CWM LLC boosted its stake in shares of ICU Medical by 341.2% in the fourth quarter. CWM LLC now owns 578 shares of the medical instruments supplier's stock worth $58,000 after buying an additional 447 shares during the last quarter. SG Americas Securities LLC acquired a new stake in ICU Medical during the fourth quarter worth about $106,000. Knights of Columbus Asset Advisors LLC raised its position in ICU Medical by 16.7% during the third quarter. Knights of Columbus Asset Advisors LLC now owns 1,848 shares of the medical instruments supplier's stock valued at $220,000 after acquiring an additional 264 shares in the last quarter. Finally, Xponance Inc. lifted its holdings in ICU Medical by 17.8% in the third quarter. Xponance Inc. now owns 2,902 shares of the medical instruments supplier's stock valued at $345,000 after acquiring an additional 439 shares during the period. Institutional investors and hedge funds own 96.10% of the company's stock.

Insider Buying and Selling at ICU Medical

In other news, VP Daniel Woolson sold 791 shares of the firm's stock in a transaction that occurred on Friday, March 15th. The stock was sold at an average price of $98.27, for a total value of $77,731.57. Following the transaction, the vice president now owns 13,980 shares in the company, valued at $1,373,814.60. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, COO Christian B. Voigtlander sold 13,603 shares of the company's stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $107.19, for a total value of $1,458,105.57. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Daniel Woolson sold 791 shares of ICU Medical stock in a transaction that occurred on Friday, March 15th. The stock was sold at an average price of $98.27, for a total value of $77,731.57. Following the transaction, the vice president now owns 13,980 shares in the company, valued at approximately $1,373,814.60. The disclosure for this sale can be found here. Insiders have sold a total of 24,262 shares of company stock valued at $2,545,532 over the last ninety days. Corporate insiders own 6.70% of the company's stock.

Analysts Set New Price Targets

Separately, KeyCorp raised their price objective on shares of ICU Medical from $134.00 to $136.00 and gave the stock an "overweight" rating in a research note on Wednesday, February 28th. One investment analyst has rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, ICU Medical has an average rating of "Moderate Buy" and a consensus price target of $123.00.

ICU Medical Price Performance

Shares of NASDAQ:ICUI traded up $2.56 during trading on Monday, reaching $97.40. 151,720 shares of the company's stock traded hands, compared to its average volume of 249,406. The firm has a market cap of $2.37 billion, a PE ratio of -79.19 and a beta of 0.69. ICU Medical, Inc. has a fifty-two week low of $78.28 and a fifty-two week high of $212.43. The company has a quick ratio of 1.06, a current ratio of 2.53 and a debt-to-equity ratio of 0.74. The company has a 50-day simple moving average of $101.40 and a 200-day simple moving average of $97.52.

ICU Medical (NASDAQ:ICUI - Get Free Report) last issued its quarterly earnings data on Tuesday, February 27th. The medical instruments supplier reported $1.24 EPS for the quarter, beating the consensus estimate of $0.85 by $0.39. ICU Medical had a positive return on equity of 6.35% and a negative net margin of 1.31%. The company had revenue of $587.86 million for the quarter, compared to analyst estimates of $564.77 million. As a group, analysts predict that ICU Medical, Inc. will post 3.53 earnings per share for the current year.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.